Karachi: AGP Limited has announced that its Board of Directors will convene on Thursday, October 29, 2026, to deliberate over the company's third quarterly financial statements for the period ending September 30, 2026. The meeting is set to take place at 02:00 P.M. at the company's headquarters located at B-23-C, S.I.T.E., Karachi, with provisions for virtual participation.

In preparation for this meeting, AGP Limited has instituted a "Closed Period" from October 23, 2026, to October 29, 2026, inclusive of both dates. This move adheres to Clause 5.6.4 of the Pakistan Stock Exchange (PSX) Regulations. During this period, the company's Directors, CEO, and Executives are prohibited from engaging in any transactions involving the company's shares, whether directly or indirectly.

According to information available from the Pakistan Stock Exchange (PSX), AGP Limited's upcoming board meeting will play a crucial role in determining the company's financial direction and potential entitlements for stakeholders. The financial outcomes of this meeting are highly anticipated by market participants, given the strategic importance of the third quarter in the company's fiscal year.

The pharmaceutical company's adherence to regulatory requirements and strategic scheduling of board meetings emphasize its commitment to transparency and robust governance practices. The outcomes of this meeting will be closely monitored by both investors and industry analysts within the designated market category.